Highly Potent, Perfectly Packaged

PCI Pharma Services has invested in a best-in-class clinical to commercial scale potent packaging suite at its Tredegar, UK, site. The goal? To provide a truly integrated end-to-end service for clients – from the manufacturing of highly potent drug products to packaging.

06/08/2022 | 8 min read | Interview

sponsored by PCI

Highly potent APIs (HPAPIs) are highly challenging, and not all CDMOs have the true capability to manufacture or package them. PCI Pharma Services has significant experience in the handling of highly potent products and has recently further invested in its Tredegar site in Wales, UK by adding a second contained manufacturing facility and a state-of-the-art potent packaging suite. In this roundtable, PCI experts run us through the project by discussing the attention to technical detail required to ensure that the required high standards and regulatory controls were not only met but also exceeded.

Rob Jones: Executive Director, Business Development, Manufacturing EMEA/APAC
Adam Pugsley: Program Lead for CAPEX Projects
Natashia Eales: Head of Technical and Regulatory Quality
Shaun Engelhardt: CAPEX Programme Manager
Ben Potter: Validation Manager

Download pdf

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.